Antibacterial Drugs Market
Antibacterial Drugs Market Analysis by Drug Class (?-lactam, Quinolone, Macrolide, Tetracycline Antibacterial Drugs), by Route of Administration (Enteral, Parenteral Antibacterial Drug Administration), by Distribution Channel & by Region - Global Insights 2021 to 2031
Analysis of Antibacterial Drugs Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Antibacterial Drugs Market Outlook (2021 to 2031)
The global antibacterial drugs market, the market is projected to expand at a CAGR of 2.6% over the forecast period (2021-2031), and reach a valuation of over US$ 62 Bn by 2031-end, and surpassing US$ 51 Bn by 2025. As of the next half-a-decade, the market is anticipated to register a CAGR of 1.5%. Demand for β-lactams will be the highest, clocking a CAGR of 2% through 2031.
Points Covered in Antibacterial Drugs Industry Survey
- Market Estimates and Forecasts (2016-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand Share and Market Share Analysis
- Key Product Innovations and Regulatory Climate
- Assessment by Product Grade / Purity / Formulation Standards
- Assessment of Import Price, Bulk Price, Contractual Price, Producer / Distributor Price
- Certifications and Compliance Requirements
- COVID-19 Impact on the Antibacterial Drugs Industry and How to Navigate
- Recommendation on Key Winning Strategies
Consumption Analysis of Antibacterial Drugs 2016-2020 Vs Outlook 2021-2031
As per Fact.MR – a market research and competitive intelligence provider, during the historic period of 2016 to 2020, the market for antibacterial drugs registered sluggish growth, expanding at around 1% of CAGR. Ongoing research to develop powerful formulation owing to rising antibiotic resistance has led to the launch of a limited number of drugs into the market.
Growth prospects took a backseat amidst the COVID-19 pandemic, as healthcare providers redirected funding and research towards developing anti-COVID vaccinations and drugs. Although several nations have inoculated their population, an oral drug is expected to take a significant amount of time to be introduced, which may cause a slowdown in the scope for formulating antibacterials.
Considering these factors, Fact.MR projects the global market for antibacterial drugs to expand at a CAGR of 2.6% across the forecast period 2021-2031. As per the report, the industry is poised to reach US$ 62 Bn by the end of the aforementioned period.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
How will R&D Activities Drive Market Growth of Antibacterial Drugs?
All the developed and emerging economies are conducting various research and development activities for the new anti-bacterial drug development. Governments have been regulating the testing of the efficacy and safety of the newly developed antibacterial drugs.
For instance, Clinical Trials Transformative Initiative (CTTI) has created approaches for streamlining antibacterial drug development that will help in designing clinical trials that better assess the efficacy and safety of new antibacterial drugs and inform clinical trial planning, recruitment, enrollment, and feasibility.
Are E-Pharmacies Propelling the Market for Antibacterial Drugs?
The market for antibacterial drugs is witnessing substantial growth, with a relatively slim drug pipeline further dampening market prospects. However, conscientious efforts taken by the governments of numerous countries, especially in Europe and North America, are projected to lead to an upsurge in the development of branded drugs.
For instance, in February 2021, the U.S. Food and Drug Administration announced the creation of the Center of Drug Evaluation and Research (CDER) Antibacterial Drug Development Task Force to support the development of new antibacterial drugs.
Also, e-pharmacies will be a full-fledged distribution channel in the future, which will enable next-day/same-day delivery, and help validate the credibility of prescriptions. An estimated 1 in 10 medical products circulating in low- and middle-income countries is either substandard or falsified, according to new research from World Health Organization.
E-Pharmacies ensure a genuine drug supply, sourcing it directly from manufacturers and licensed resellers. E-retailers conform to government regulations, which further increases the reliance of patients on e-pharmacies. Given the rise of this new revenue stream, the market will register a healthy growth rate.
Country-Wise Analysis
Why is North America a Lucrative Market for Antibacterial Drugs?
North America is projected to dominate the global market during the forecast period owing to a highly structured health care industry, increasing prevalence of infectious diseases, and introduction of novel products in the region.
Furthermore, regional incidence of antimicrobial resistant infections are surging manifold. The Centers for Disease Control and Prevention estimates that at least 2.8 million people contract an antibiotic-resistant infection, with more than 35,000 fatalities each year.
Consequently, healthcare providers are working ceaselessly to develop advanced formulations. As of 2020, the Infectious Diseases Society of America (IDSA) has been working on the 10 x 20 initiative, seeking a global commitment to create an antibiotic R&D enterprise to produce 10 new systematic antibiotics by the end of that year. The region will likely account for 33% market demand.
How is Asia Projected to Perform in the Market for Antibacterial Drugs?
Fact.MR forecasts the Asian market for antibacterial drugs to exhibit the dominant market share, accounting for 50% of total revenue. Factors such as increasing patient population, initiatives by the developing economies in the healthcare sector, rising geriatric population, and growing incidence of infectious diseases are spurring adoption in the region.
Japan holds significant opportunities for the market players, on the back of a large patient pool that includes the geriatric population, coupled with a well-established distribution network. Besides this, given the technological advancements in Japan, e-pharmacies will remain an integral sales channel in the future. Numerous companies such as Aspen Pharma Holdings, Sun Pharmaceuticals, and Lupin continue to invest in Japan to cash in on the profitable opportunities available in this market.
What are the Growth Prospects across Europe?
Demand for novel and effective drugs, on account of progressive acceptance of the out-of-pocket payment model, is projected to draw high sales possibilities. The low cost of generic drugs will continue to fuel market growth in the region during the forecast period.
In 2020, the European Commission announced a Pharmaceutical Strategy for Europe which offers a unique opportunity to deliver a policy that provides EU citizens with medicines that bring additional therapeutic benefits at a price they are able to pay.
Europe’s pharmaceutical sector contributes majorly to the EU economy in terms of creation of highly skilled jobs and innovation. In addition to this, digitalization and innovation are opening new possibilities. Fact.MR expects the European market to capture around 35% of the revenue.
Category-wise Insights
Which Drug Class is projected to Witness the Highest Demand?
There has been a marked uptake in the sales of β-lactam, as these are indicated for the prevention and treatment of bacterial infections. Continuous progression in the development of effective β-lactam is deemed as a primary growth indicator of this drug class.
For example, initially, β-lactam drugs were active only against gram-positive bacteria. However, in recent times, these are showing resistance against gram-negative organisms as well, which is expected to further drive their popularity. The segment is poised to register a CAGR of over 2% until 2031.
How are Retail Pharmacies Creating Opportunities?
The retail pharmacies and drug stores segment is anticipated to grow significantly during the forecast period owing to the increasing number of retail drugs stores, and the availability of antibacterial drugs through retail pharmacies and drugs stores.
Currently, e-pharmacies witness challenges, such as non-compliance of e-retailers with government regulations, concerns regarding the credibility of prescription, drug counterfeiting, and delay in shipping. However, in the future, this distribution channel will remain integral in driving sales from overseas markets. The segment is expected to account for over 40% revenue.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Competitive Landscape
Competition in the global market for antibacterial drugs is expected to rise, with players focusing on gaining competitive advantage and increasing their market foothold. Manufacturers can seek partnerships with government organizations to gain financial support for the development of drugs, and, in turn, position themselves as distinguished players in the global market.
- In September 2021, Myovant Sciences and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) accepted for review a supplemental New Drug Application (sNDA) for MYFEMBREE® (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg) for the management of moderate to severe pain associated with endometriosis.
- In July 2021, AstraZeneca announced that it has entered into a collaboration with Regeneron to research, develop and commercialize small molecule compounds directed against the GPR75 target with the potential to treat obesity and related co-morbidities.
Report Scope
| Attributes | Details |
|---|---|
|
Market size value in 2020 |
USD 48 Billion |
|
Market forecast value in 2031 |
USD 62 Billion |
|
Growth Rate (2021-2031) |
CAGR of 2.6% |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
Key Segments Covered
-
By Drug Class :
- β-lactam
- Quinolone
- Macrolide
- Tetracycline
- Aminoglycoside
- Sulfonamide
- Phenicols
- Other
-
By Route of Administration :
- Enteral
- Parenteral
- Other
-
By Distribution Channel :
- Hospital Pharmacies
- Drug Stores and Retail Pharmacies
- Online Antibacterial Drug Sales
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa
Table of Content
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Assumptions and Acronyms Used 2. Research Methodology 3. Executive Summary 4. Market Overview 4.1. Product Overview 4.2. Key Industry Developments 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunity Analysis 4.3.4. Porter’s Five Forces Representation 4.3.5. Antibacterial Drugs Market- Value Chain Analysis & Supply-Demand Scenario 4.3.6. Antibacterial Drugs Market Outlook 4.3.7. Anti-Bacterial Drugs Pipeline Analysis 5. Global Antibacterial Drugs Market Analysis, by Drug Class, 2021 – 2031 5.1. Key Findings 5.2. Definition 5.3. Introduction 5.4. Global Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031 5.5. Global Antibacterial Drugs Market Analysis, by Drug Class 5.5.1. β-lactam 5.5.2. Quinolones 5.5.3. Macrolides 5.5.4. Tetracycline 5.5.5. Aminoglycoside 5.5.6. Sulfonamide 5.5.7. Phenicols 5.5.8. Others 5.6. Global Antibacterial Drugs Market Attractiveness Analysis, by Drug Class 5.7. Global Antibacterial Drugs Market Forecast, by Drug Class 5.8. Key Trends 6. Global Antibacterial Drugs Market Analysis, by Routes of Administration 6.1. Key Findings 6.2. Definitions 6.3. Introduction 6.4. Global Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031 6.5. Global Antibacterial Drugs Market Analysis, by Routes of Administration 6.5.1. Enteral 6.5.2. Parenteral 6.5.3. Others 6.6. Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration 6.7. Global Antibacterial Drugs Market Forecast, by Routes of Administration 7. Global Antibacterial Drugs Market Analysis, by Channels of Distribution 7.1. Key Findings 7.2. Definitions 7.3. Introduction 7.4. Global Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031 7.5. Global Antibacterial Drugs Market Analysis, by Channels of Distribution 7.5.1. Hospital Pharmacies 7.5.2. Drug Stores & Retail Pharmacies 7.5.3. Online Sales 7.6. Global Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution 7.7. Global Antibacterial Drugs Market Forecast, by Channels of Distribution 7.8. Key Trends 8. Global Antibacterial Drugs Market Analysis, by Region 8.1. Key Findings 8.2. Introduction 8.3. Global Antibacterial Drugs Market Value Share Analysis, by Region, 2020 and 2031 8.4. Global Antibacterial Drugs Market Attractiveness Analysis, by Region, 2020 8.5. Global Antibacterial Drugs Market Forecast, by Region, 2021–2031 9. North America Antibacterial Drugs Market Analysis 9.1. North America Antibacterial Drugs Market Overview 9.2. North America Antibacterial Drugs Market Forecast, Country wise, 2021–2031 9.3. North America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031 9.4. North America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020 9.5. North America Antibacterial Drugs Market Forecast, by Drug Class, 2021–2031 9.6. North America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031 9.7. North America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2020 9.8. North America Antibacterial Drugs Market Forecast, by Routes of Administration, 2021–2031 9.9. North America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031 9.10. North America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2020 9.11. North America Antibacterial Drugs Market Forecast, by Channels of Distributions, 2021–2031 9.12. Key Trends 10. Europe Antibacterial Drugs Market Analysis 10.1. Europe Antibacterial Drugs Market Overview 10.2. Europe Antibacterial Drugs Market Forecast, Country wise, 2021–2031 10.3. Europe Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031 10.4. Europe Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020 10.5. Europe Antibacterial Drugs Market Forecast, by Drug Class, 2021–2031 10.6. Europe Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031 10.7. Europe Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2020 10.8. Europe Antibacterial Drugs Market Forecast, by Routes of Administration, 2021–2031 10.9. Europe Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031 10.10. Europe Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2020 10.11. Europe Antibacterial Drugs Market Forecast, by Channels of Distributions, 2021–2031 10.12. Key Trends 11. Asia Pacific Antibacterial Drugs Market Analysis 11.1. Asia Pacific Antibacterial Drugs Market Overview 11.2. Asia Pacific Antibacterial Drugs Market Forecast, Country wise, 2021–2031 11.3. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031 11.4. Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020 11.5. Asia Pacific Antibacterial Drugs Market Forecast, by Drug Class, 2021–2031 11.6. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031 11.7. Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2020 11.8. Asia Pacific Antibacterial Drugs Market Forecast, by Routes of Administration, 2021–2031 11.9. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031 11.10. Pacific Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2020 11.11. Asia Pacific Antibacterial Drugs Market Forecast, by Channels of Distributions, 2021–2031 11.12. Key Trends 12. Latin America Antibacterial Drugs Market Analysis 12.1. Latin America Antibacterial Drugs Market Overview 12.2. Latin America Antibacterial Drugs Market Forecast, Country wise, 2021–2031 12.3. Latin America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031 12.4. Latin America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020 12.5. Latin America Antibacterial Drugs Market Forecast, by Drug Class, 2021–2031 12.6. Latin America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031 12.7. Latin America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2020 12.8. Latin America Antibacterial Drugs Market Forecast, by Routes of Administration, 2021–2031 12.9. Latin America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031 12.10. Latin America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2020 12.11. Latin America Antibacterial Drugs Market Forecast, by Channels of Distributions, 2021–2031 12.12. Key Trends 13. Middle East & Africa Antibacterial Drugs Market Analysis 13.1. Middle East & Africa Antibacterial Drugs Market Overview 13.2. Middle East & Africa Antibacterial Drugs Market Forecast, Country wise, 2021–2031 13.3. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031 13.4. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020 13.5. Middle East & Africa Antibacterial Drugs Market Forecast, by Drug Class, 2021–2031 13.6. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031 13.7. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2020 13.8. Middle East & Africa Antibacterial Drugs Market Forecast, by Routes of Administration, 2021–2031 13.9. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031 13.10. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2020 13.11. Middle East & Africa Antibacterial Drugs Market Forecast, by Channels of Distributions, 2021–2031 13.12. Key Trends 14. Competition Landscape 14.1. Leading Antibacterial Drugs Sales Analysis, 2014 – 2020 14.2. Competition Matrix 14.3. Company Profiles 14.3.1. Bayer AG 14.3.1.1. Company Description 14.3.1.2. Business Overview 14.3.1.3. SWOT Analysis 14.3.1.4. Strategic Overview 14.3.2. Pfizer Inc. 14.3.2.1. Company Description 14.3.2.2. Business Overview 14.3.2.3. SWOT Analysis 14.3.2.4. Strategic Overview 14.3.3. Sanofi 14.3.3.1. Company Description 14.3.3.2. Business Overview 14.3.3.3. SWOT Analysis 14.3.3.4. Strategic Overview 14.3.4. GlaxoSmithKline plc 14.3.4.1. Company Description 14.3.4.2. Business Overview 14.3.4.3. SWOT Analysis 14.3.4.4. Strategic Overview 14.3.5. Merck & Co., Inc 14.3.5.1. Company Description 14.3.5.2. Business Overview 14.3.5.3. SWOT Analysis 14.3.5.4. Strategic Overview 14.3.6. AstraZeneca 14.3.6.1. Company Description 14.3.6.2. Business Overview 14.3.6.3. SWOT Analysis 14.3.6.4. Strategic Overview 14.3.7. Johnson and Johnson 14.3.7.1. Company Description 14.3.7.2. Business Overview 14.3.7.3. SWOT Analysis 14.3.7.4. Strategic Overview 14.3.8. Bristol-Myers Squibb Company 14.3.8.1. Company Description 14.3.8.2. Business Overview 14.3.8.3. SWOT Analysis 14.3.8.4. Strategic Overview 14.3.9. Novartis AG 14.3.9.1. Company Description 14.3.9.2. Business Overview 14.3.9.3. SWOT Analysis 14.3.9.4. Strategic Overview 14.3.10. Allergen Plc. 14.3.10.1. Company Description 14.3.10.2. Business Overview 14.3.10.3. SWOT Analysis 14.3.10.4. Strategic Overview
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2021–2031
Table 02: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2021–2031
Table 03: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2021–2031
Table 04: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Region, 2021–2031
Table 05: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, Country Wise, 2021–2031
Table 06: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2021–2031
Table 07: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2021–2031
Table 08: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distributions, 2021–2031
Table 09: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, Country Wise, 2021–2031
Table 10: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2021–2031
Table 11: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2021–2031
Table 12: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2021–2031
Table 13: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, Country Wise, 2021–2031
Table 14: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2021–2031
Table 15: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2021–2031
Table 16: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2021–2031
Table 17: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Country Wise, 2021–2031
Table 18: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2021–2031
Table 19: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration,2021–2031
Table 20: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2021–2031
Table 21: Middle East & Africa Antibacterial Drugs Market Size (US$ Mn) Forecast, by Country Wise, 2021–2031
Table 22: Middle East & Africa Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2021–2031
Table 23: MEA Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2021–2031
Table 24: MEA Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2021–2031
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Antibacterial Drugs Market Size ($ Mn) and Distribution by Geography, 2017 and 2031
Figure 02: Global Antibacterial Drugs Market Revenue (US$ Mn) and top 3 trends
Figure 03: Global Antibacterial Drugs Market, by Channels of Distribution, Revenue (US$ Mn) and Market Share
Figure 04: Market Value Share By Drug Class (2017) Revenue (US$ Mn)
Figure 05: Market Value Share By Region (2017) Revenue (US$ Mn)
Figure 06: Antibacterial Drugs in Clinical Trials
Figure 07: Anti-bacterial Drugs by Indication
Figure 08: Anti-bacterial Drugs by class
Figure 09: Global Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031
Figure 10: Global β-lactam Market Revenue (US$ Mn) and Y-o-Y Growth (%), by β-lactam, 2021–2031
Figure 11: Global Quinolones Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 12: Global Macrolides Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 13: Global Tetracyclines Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 14: Global Aminoglycosides Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 15: Global Sulfonamides Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 16: Global Phenicols Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 17: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 18: Global Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020
Figure 19: Global Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031
Figure 20: Global Enteral Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 21: Global Parenteral Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 22: Global Others routes of administration Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 23: Global Antibacterial Drugs Market Attractiveness Analysis, by Routes od Administration, 2020
Figure 24: Global Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031
Figure 25: Global Hospital Pharmacies Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 26: Global Drug Stores & Retail Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 27: Global Online Sales Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2021–2031
Figure 28: Global Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2020
Figure 29: Global Antibacterial Drugs Market Value Share Analysis, by Region, 2020 and 2031
Figure 30: Global Antibacterial Drugs Market Attractiveness Analysis, by Region, 2020
Figure 31: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, 2021–2031
Figure 32: North America Antibacterial Drugs Market Y-o-Y Growth Projections, 2021–2031
Figure 33: North America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031
Figure 34: North America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020
Figure 35: North America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031
Figure 36: North America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration,2020
Figure 37: North America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031
Figure 38: North America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2020
Figure 39: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, 2021–2031
Figure 40: Europe Antibacterial Drugs Market Y-o-Y Growth Projections, 2021–2031
Figure 41: Europe Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031
Figure 42: Europe Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020
Figure 43: Europe Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031
Figure 44: Europe Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2020
Figure 45: Europe Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031
Figure 46: Europe Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2020
Figure 47: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, 2021–2031
Figure 48: Asia Pacific Antibacterial Drugs Market Y-o-Y Growth Projections, 2017–2031
Figure 49: Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031
Figure 50: Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020
Figure 51: Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031
Figure 52: Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2020
Figure 53: Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031
Figure 54: Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2020
Figure 55: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, 2021–2031
Figure 56: Latin America Antibacterial Drugs Market, Y-o-Y Growth Projection, 2021–2031
Figure 57: Latin America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031
Figure 58: Latin America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020
Figure 59: Latin America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031
Figure 60: Latin America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2020
Figure 61: Latin America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031
Figure 62: Latin America Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2020
Figure 63: Middle East & Africa Antibacterial Drugs Market Size (US$ Mn) Forecast, 2021–2031
Figure 64: Middle East & Africa Antibacterial Drugs Market Y-o-Y Growth Projections, 2021–2031
Figure 65: Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2020 and 2031
Figure 66: Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2020
Figure 67: MEA Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2020 and 2031
Figure 68: MEA Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2020
Figure 69: MEA Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2020 and 2031
Figure 70: MEA Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2020
Figure 71: Leading Antibacterial Drugs Sales Analysis, 2014 – 2020
Figure 72: Bayer AG, Breakdown of Net Sales, by Region, 2020
Figure 73: Bayer AG, Revenue (US$ Mn) & Y-o-Y Growth (%), 2016–2020
Figure 74: Pfizer, Breakdown of Net Sales, by Region, 2020
Figure 75: Pfizer, Revenue (US$ Bn) & Y-o-Y Growth (%), 2016–2020
Figure 76: Sanofi, Breakdown of Net Sales, by Region, 2020
Figure 77: Sanofi, Revenue (US$ Bn) & Y-o-Y Growth (%), 2016–2020
Figure 78: GlaxoSmithKline, Breakdown of Net Sales, by Region, 2020
Figure 79: GlaxoSmithKline, Revenue (US$ Bn) & Y-o-Y Growth (%), 2016–2020
Figure 80: Merck & Co., Breakdown of Net Sales, by Region, 2020
Figure 81: Merck & Co., Revenue (US$ Mn) & Y-o-Y Growth (%), 2016–2020
Figure 82: AstraZeneca, Breakdown of Net Sales, by Region, 2020
Figure 83: AstraZeneca, Revenue (US$ Bn) & Y-o-Y Growth (%), 2016–2020
Figure 84: Johnson & Johnson, Breakdown of Net Sales, by Region, 2020
Figure 85: Johnson & Johnson, Revenue (US$ Bn) & Y-o-Y Growth (%), 2016–2020
Figure 86: Bristol-Myers Squibb Company, Breakdown of Net Sales, by Region (2020)
Figure 87: Bristol-Myers Squibb Company, Revenue (US$ Bn) & Y-o-Y Growth (%), 2016–2020
Figure 88: Novartis AG, Breakdown of Net Sales, by Region, 2020
Figure 89: Novartis AG, Revenue (US$ Bn) & Y-o-Y Growth (%), 2016–2020
Figure 90: Allergen, Breakdown of Net Sales (%), by Segments (2020)
Figure 91: Allergen, Revenue (US$ Bn) & Y-o-Y Growth (%), 2016–2020
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the antibacterial drugs industry worth?
As of 2021, the market for antibacterial drugs is expected to reach US$ 48 Bn
What is the projected market value of the antibacterial drugs?
The global market for antibacterial drugs is envisaged to account for over US$ 62 Bn by 2031.
What was the last 5 years CAGR for the antibacterial drugs industry?
From 2016 to 2020, antibacterial drugs landscape expanded at a sluggish 1% CAGR
What are the short-term market growth prospects?
By 2025, demand for antibacterial drugs is likely to surge at a CAGR of 1.5% to reach US$ 50 Bn as per Fact.MR
What is currently driving demand for antibacterial drugs?
Unceasing R&D activities to discover novel formulations to counter the ever growing antibiotic resistance is expected to fuel future expansion prospects
Which drug class is likely to lead market growth?
β-lactam antibacterial drugs are expected to remain prominent, surging at 2% CAGR
What is the outlook for the North American market?
North America is poised to account for 1/3rd of the global antibacterial drugs demand through 2031
How do prospects appear across Asia?
50% of global antibacterial drug sales are expected to occur across Asia
How opportunistic is the market in Europe?
Europe is expected to yield around 35% of the market revenue for antibacterial drugs until 2031
Which distribution is widely preferred for selling antibacterial drugs?
Drug stores & retail pharmacies are most preferred, accounting for 40% of total sales
Antibacterial Drugs Market